Vitamin B₁₂ and its binding proteins in hepatocellular carcinoma and chronic liver diseases

References

• Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005;9:191–211.
   PubMed Web of Science ®Google Scholar
• Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003;52:1111–18.
   PubMedGoogle Scholar
• Ermens AA, Vlasveld LT, Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 2003;36:585–90.
   PubMed Web of Science ®Google Scholar
• Arendt JF, Quadros EV, Nexo E. Soluble transcobalamin receptor, sCD320, is present in human serum and relates to serum cobalamin - establishment and validation of an ELISA. Clin Chem Lab Med 2011;50:515–19.
   PubMedGoogle Scholar
• Nexo E, Olesen H, Norredam K, Schwartz M. A rare case of megaloblastic anaemia caused by disturbances in the plasma cobalamin binding proteins in a patient with hepatocellular carcinoma. Scand J Haematol 1975;14:320–7.
   PubMedGoogle Scholar
• Lildballe DL, Nguyen KQ, Poulsen SS, Nielsen HO, Nexo E. Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma. Eur J Surg Oncol 2011;37:72–9.
   PubMed Web of Science ®Google Scholar
• Kanai T, Takabayashi T, Kawano Y, Kuramochi S, Miyazawa N. A case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B12 binding capacity in a young Japanese female. Jpn J Clin Oncol 2004;34:346.
   PubMed Web of Science ®Google Scholar
• Boisson F, Fremont S, Migeon C, Nodari F, Droesch S, Gerard P, et al. Human haptocorrin in hepatocellular carcinoma. Cancer Detect Prev 1999;23:89–96.
   PubMedGoogle Scholar
• Kane SP, Murray-Lyon IM, Paradinas FJ, Johnson PJ, Williams R, Orr A, et al. Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma. Gut 1978;19:1105–9.
   PubMed Web of Science ®Google Scholar
• Morbak A, Poulsen SS, Nexo E. Haptocorrin in humans. Clin Chem Lab Med 2007;45:1751–9.
   PubMedGoogle Scholar
• Burger RL, Schneider RJ, Mehlman CS, Allen RH. Human plasma R-type vitamin B12-binding proteins. II. The role of transcobalamin I, transcobalamin III, and the normal granulocyte vitamin B12-binding protein in the plasma transport of vitamin B12. J Biol Chem 1975;250:7707–13.
   PubMed Web of Science ®Google Scholar
• Osifo BO, Ayoola A, Parmentier Y, Gerard P, Nicolas JP. Correlation between serum enzymes and serum unsaturated vitamin B12 binding proteins in primary liver carcinoma. Enzyme 1988;39:161–6.
   PubMedGoogle Scholar
• Fremont S, Champigneulle B, Gerard P, Felden F, Lambert D, Gueant JL, et al. Blood transcobalamin levels in malignant hepatoma. Tumour Biol 1991;12:353–9.
   PubMed Web of Science ®Google Scholar
• Baker H, Leevy CB, DeAngelis B, Frank O, Baker ER. Cobalamin (vitamin B12) and holotranscobalamin changes in plasma and liver tissue in alcoholics with liver disease. J Am Coll Nutr 1998;17:235–8.
   PubMed Web of Science ®Google Scholar
• Joske RA. The vitamin B12 content of human liver tissue obtained by aspiration biopsy. Gut 1963;4:231–5.
   PubMedGoogle Scholar
• Lambert D, Benhayoun S, Adjalla C, Gelot MM, Renkes P, Gerard P, et al. Alcoholic cirrhosis and cobalamin metabolism. Digestion 1997;58:64–71.
   PubMedGoogle Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020–2.
   PubMed Web of Science ®Google Scholar
• Rode A, Nicoll A, Moller HJ, Lim L, Angus PW, Kronborg I, et al. Hepatic macrophage activation predicts clinical decompensation in chronic liver disease. Gut 2013;62:1231–2.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329–38.
   PubMed Web of Science ®Google Scholar
• Morkbak AL, Pedersen JF, Nexo E. Glycosylation independent measurement of the cobalamin binding protein haptocorrin. Clin Chim Acta 2005;356:184–90.
   PubMed Web of Science ®Google Scholar
• Nexo E, Christensen AL, Petersen TE, Fedosov SN. Measurement of transcobalamin by ELISA. Clin Chem 2000;46:1643–9.
   PubMed Web of Science ®Google Scholar
• Nexo E, Christensen AL, Hvas AM, Petersen TE, Fedosov SN. Quantification of holo-transcobalamin, a marker of vitamin B12 deficiency. Clin Chem 2002;48:561–2.
   PubMed Web of Science ®Google Scholar
• Waxman S, Liu CK, Schreiber C, Helson L. The clinical and physiological implications of hepatoma B12-binding proteins. Cancer Res 1977;37:1908–14.
   PubMedGoogle Scholar
• Stibler H, Hultcrantz R. Carbohydrate-deficient transferrin in serum in patients with liver diseases. Alcohol Clin Exp Res 1987;11:468–73.
   PubMed Web of Science ®Google Scholar
• Meregalli M, Giacomini V, Lino S, Marchetti L, DeFeo T, Cappellini MD, et al. Carbohydrate-deficient transferrin in alcohol and nonalcohol abusers with liver disease. Alcohol Clin Exp Res 1995;19:1525–7.
   PubMed Web of Science ®Google Scholar
• Sawamura T, Nakada H, Hazama H, Shiozaki Y, Sameshima Y, Tashiro Y. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroenterology 1984;87:1217–21.
   PubMed Web of Science ®Google Scholar
• Moller HJ, Moestrup SK, Weis N, Wejse C, Nielsen H, Pedersen SS, et al. Macrophage serum markers in pneumococcal bacteremia: prediction of survival by soluble CD163. Crit Care Med 2006;34:2561–6.
   PubMed Web of Science ®Google Scholar
• Hoffmann-Lucke E, Arendt JF, Nissen PH, Mikkelsen G, Aasly JO, Nexo E. Three family members with elevated plasma cobalamin, transcobalamin and soluble transcobalamin receptor (sCD320). Clin Chem Lab Med 2013;51:677–82.
   PubMedGoogle Scholar
• Abuyaman O, Andreasen BH, Kronborg C, Vittinghus E, Nexo E. The soluble receptor for vitamin B12 uptake (sCD320) increases during pregnancy and occurs in higher concentration in urine than in serum. PLoS One 2013;8:e73110.
   PubMed Web of Science ®Google Scholar